Recruiting NA Brain Metastases, Adult

Compares treatment options for Brain Metastases, Adult

Official title Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases

ClinicalTrials.gov ID: NCT05545007

What this study is testing

What it's testing
This is a phase III randomized trial with the aim to compare preoperative HSRS to postoperative HSRS in patients with large at least one BMs from solid tumors suitable for surgical resection.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age \>18 years
  • Histological or cytological or radiological confirmation of solid tumor malignancy
  • Clinical indication for surgical resection of one brain metastasis
  • Karnosky performance status (KPS) ≥70
  • Controlled or responsive extra cranial metastatic lesions

You likely can't join if

  • Prior WBRT
  • KPS \< 70
  • Diagnosis of small cell lung cancer (SCLC), germinal cell tumour or Lymphoproliferative disease
  • Pregnant women
  • Prior open neurosurgery for malignancy
  • More than 4 brain metastases
See the full eligibility criteria
Who can join
  • Age \>18 years
  • Histological or cytological or radiological confirmation of solid tumor malignancy
  • Clinical indication for surgical resection of one brain metastasis
  • Karnosky performance status (KPS) ≥70
  • Controlled or responsive extra cranial metastatic lesions
  • Limited brain metastases (1-4 BMs)
  • Single metastatic lesion ≥ 2.1 cm in maximum diameter (4 cm3)
  • Lesions ≤2 cm conditioning mass effect or neurological deficits or massive edema unresponsive to steroids
  • Written informed consent form
What rules you out
  • Prior WBRT
  • KPS \< 70
  • Diagnosis of small cell lung cancer (SCLC), germinal cell tumour or Lymphoproliferative disease
  • Pregnant women
  • Prior open neurosurgery for malignancy
  • More than 4 brain metastases
  • Patients with incompatibility to perform MRI

The study team makes the final eligibility decision.

Where it's taking place

  • Brescia, Brescia, Italy
  • Florence, Florence, Italy
  • Rozzano, Milano, Italy
  • Milan, Milan, Italy
  • Naples, Naples, Italy
  • Rome, Rome, Italy
  • Terni, Terni, Italy

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Brescia, Brescia, Italy; Florence, Florence, Italy; Rozzano, Milano, Italy; Milan, Milan, Italy; Naples, Naples, Italy; Rome, Rome, Italy and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.